FAC MEDICINA
Centro
University of Auckland
Auckland, Nueva ZelandaPublicaciones en colaboración con investigadores/as de University of Auckland (12)
2024
2022
-
Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery
Trials, Vol. 23, Núm. 1
-
Tranexamic Acid in Patients Undergoing Noncardiac Surgery
New England Journal of Medicine, Vol. 386, Núm. 21, pp. 1996-1997
2021
-
Goal achievement and adaptive goal adjustment in a behavioral intervention for participants with prediabetes
Journal of Health Psychology, Vol. 26, Núm. 14, pp. 2743-2755
2020
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73
2019
-
Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
The Lancet, Vol. 394, Núm. 10193, pp. 139-147
-
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911
2018
-
Gene Editing of Stem Cells to Model and Treat Disease
Current Stem Cell Reports, Vol. 4, Núm. 3, pp. 253-263
-
Objectively measured physical activity and sedentary time are associated with cardiometabolic risk factors in adults with prediabetes: The PREVIEW study
Diabetes Care, Vol. 41, Núm. 3, pp. 562-569
2017
-
Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA
PLoS ONE, Vol. 12, Núm. 9
-
Proposed guidelines to evaluate scientific validity and evidence for genotype-based dietary advice
Genes and Nutrition, Vol. 12, Núm. 1
2016
-
Impact of gene editing on the study of cystic fibrosis
Human Genetics, Vol. 135, Núm. 9, pp. 983-992